We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
Published online by Cambridge University Press: 22 October 2009
Introduction
The primary aim of an IVF treatment cycle is the creation of two ‘good quality’ pre-embryos for transfer, with a secondary aim of additional embryos for cryo-preservation. Because of the need for sufficient oocytes for fertilization, and embryos for selection, it is necessary to stimulate sufficient follicles to generate an adequate number of mature oocytes. Recent advances towards the transfer of one or two blastocysts for transfer, sometimes after blastomere biopsy and aneuploidy screening, also requires a sufficient number of oocytes for fertilization.
Primordial follicle recruitment is determined by factors that are still to be fully determined and is independent of follicle stimulating hormone (FSH) stimulation. In a given cycle an individual woman has a certain number of follicles that will be sensitive to FSH – the main determinants being a combination of her chronological age and ovarian age (‘ovarian reserve’). There are a number of tests of ovarian reserve, which may be used singly or in combination to predict ovarian response and gonadotrophin dosage: baseline serum concentrations (FSH, inhibin, oestradiol), ovarian stimulation/challenge tests and ultrasonography (ovarian volume, primordial follicle number and blood flow).
There are a large number of regimens for superovulation in IVF protocols. The evolution of superovulation strategies has encompassed the development of new classes of drugs and has lead to improved efficiency of the treatment cycle. This chapter will outline the current options, concentrating on evidence for clinical effectiveness. Complications of treatment, such as ovarian hyperstimulation syndrome (OHSS), are dealt with elsewhere in this book.
To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Find out more about the Kindle Personal Document Service.
To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.
To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.
